Simpson Thacher represented the underwriters, led by J.P. Morgan Securities LLC, Credit Suisse (USA) LLC, Goldman Sachs & Co. LLC and Jefferies LLC in connection with the offering by certain affiliates of Warburg Pincus LLC and GTCR, LLC, as well as certain current and former members of management of Sotera Health Company (“Sotera Health”), of an aggregate of 25,000,000 shares of Sotera Health’s common stock. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of common stock. The offering raised approximately $675 million in aggregate gross proceeds for the selling stockholders and closed on March 22, 2021.
Sotera Health is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses–Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
The Simpson Thacher team for this transaction included Art Robinson, Jean Park, Kirsten Harmon and Ben Kloss (Capital Markets); Vanessa Burrows (Healthcare); Mike Isby (Environmental); Andrew Blau and Pasco Struhs (Executive Compensation and Employee Benefits); Joia Lee (Public Company Advisory Practice); Jonathan Cantor and Suzy Yaster (Tax); Andrew Pagliughi (FINRA & Blue Sky); and Alysha Sekhon (IP).